IPCALAB

Ipca Laboratories Share Price

₹1,394.00 -15 (-1.06%)

19 Apr, 2025 19:34

SIP TrendupStart SIP in IPCALAB

Start SIP

Performance

  • Low
  • ₹1,381
  • High
  • ₹1,418
  • 52 Week Low
  • ₹1,052
  • 52 Week High
  • ₹1,756
  • Open Price₹1,409
  • Previous Close₹1,409
  • Volume63,964

Investment Returns

  • Over 1 Month + 3.49%
  • Over 3 Month -9.67%
  • Over 6 Month -15.51%
  • Over 1 Year + 3.08%
SIP Lightning

Smart Investing Starts Here Start SIP with Ipca Laboratories for Steady Growth!

Invest Now

Ipca Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 48.5
  • PEG Ratio
  • 1.7
  • Market Cap Cr
  • 35,366
  • P/B Ratio
  • 5.3
  • Average True Range
  • 73.88
  • EPS
  • 31.24
  • Dividend Yield
  • 0.3
  • MACD Signal
  • -8.92
  • RSI
  • 51.13
  • MFI
  • 50.47

Ipca Laboratories Financials

Ipca Laboratories Technicals

EMA & SMA

Current Price
₹1,394.00
-15 (-1.06%)
pointer
  • stock-down_img
  • Bearish Moving Average 8
  • stock-up_img
  • Bullish Moving Average 8
  • 20 Day
  • ₹1,387.29
  • 50 Day
  • ₹1,415.97
  • 100 Day
  • ₹1,445.73
  • 200 Day
  • ₹1,419.68

Resistance and Support

1400.93 Pivot Speed
  • R3 1,458.47
  • R2 1,438.13
  • R1 1,421.27
  • S1 1,384.07
  • S2 1,363.73
  • S3 1,346.87

What's your outlook on Ipca Laboratories?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ipca Laboratories Ltd. is a global pharmaceutical company, producing over 350 formulations and 80 APIs. Operating in 120+ countries, it leads in therapeutic areas like pain, rheumatology, and antimalarials, with fully-automated facilities approved by global regulatory bodies.

Ipca Laboratories has an operating revenue of Rs. 8,725.91 Cr. on a trailing 12-month basis. An annual revenue growth of 23% is outstanding, Pre-tax margin of 11% is healthy, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 9%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 20% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 73 which is a FAIR score but needs to improve its earnings, a RS Rating of 65 which is FAIR indicating the recent price performance, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 68 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ipca Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-13 Quarterly Results
2024-11-14 Quarterly Results & Interim Dividend
2024-09-30 Others
2024-08-13 Quarterly Results
2024-05-29 Audited Results & Final Dividend
Date Purpose Remarks
2024-11-25 INTERIM Rs.2.00 per share(200%)Interim Dividend (Revised)
2023-11-22 INTERIM Rs.2.00 per share(200%)Interim Dividend (Revised)
2022-11-23 INTERIM Rs.4.00 per share(400%)Interim Dividend
2021-11-23 INTERIM Rs.8.00 per share(400%)Interim Dividend
View More
Date Purpose Remarks
2022-01-11 Split Rs.0.00 split from Rs. 2/- to Re. 1/-.

Ipca Laboratories F&O

Ipca Laboratories Shareholding Pattern

44.72%
29.63%
5.64%
10.75%
0%
6.81%
2.45%

About Ipca Laboratories

  • NSE Symbol
  • IPCALAB
  • BSE Symbol
  • 524494
  • Managing Director
  • Mr. Ajit Kumar Jain
  • ISIN
  • INE571A01038

Similar Stocks to Ipca Laboratories

Ipca Laboratories FAQs

Ipca Laboratories share price is ₹1,394 As on 19 April, 2025 | 19:20

The Market Cap of Ipca Laboratories is ₹35366.4 Cr As on 19 April, 2025 | 19:20

The P/E ratio of Ipca Laboratories is 48.5 As on 19 April, 2025 | 19:20

The PB ratio of Ipca Laboratories is 5.3 As on 19 April, 2025 | 19:20

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23